LIN · Linde PLC - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.78B | - | $8.62B | $8.49B | $8.11B | - | $8.36B | $8.27B | $8.10B | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $38.00M | - | $36.00M | $38.00M | $38.00M | - | $37.00M | $36.00M | $38.00M | - |
| SG&A | $893.00M | - | $897.00M | $870.00M | $786.00M | - | $823.00M | $840.00M | $860.00M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $951.00M | - | $961.00M | $942.00M | $910.00M | - | $960.00M | $958.00M | $949.00M | - |
| Operating Income | $2.44B | - | $2.37B | $2.35B | $2.18B | - | $2.09B | $2.18B | $2.10B | - |
| Interest Expense | $62.00M | - | $64.00M | $67.00M | $65.00M | - | $40.00M | $52.00M | - | - |
| Income Tax | $571.00M | - | $424.00M | $573.00M | $511.00M | - | $498.00M | $508.00M | $463.00M | - |
| Net Income | $1.86B | - | $1.93B | $1.77B | $1.67B | - | $1.55B | $1.66B | $1.63B | - |
| EPS - Basic | $4.00 | - | $4.11 | $3.75 | $3.53 | - | $3.24 | $3.46 | $3.38 | - |
| EPS - Diluted | $3.98 | - | $4.09 | $3.73 | $3.51 | - | $3.22 | $3.44 | $3.35 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.96B | $5.06B | $4.51B | $4.79B | $5.29B | $4.85B | $5.19B | $4.63B | $4.85B | $4.66B |
| Accounts Receivable | $5.32B | $4.97B | $5.33B | $5.23B | $4.95B | $4.62B | $4.87B | $5.00B | $5.01B | $4.72B |
| Inventory | $2.08B | $2.06B | $2.13B | $2.12B | $1.98B | $1.95B | $2.09B | $2.09B | $2.10B | $2.12B |
| Accounts Payable | $2.66B | $2.81B | $2.65B | $2.59B | $2.45B | $2.51B | $2.85B | $2.86B | $2.88B | $3.02B |
| Current Assets | $12.75B | $13.32B | $13.33B | $13.63B | $13.60B | $12.95B | $13.46B | $12.84B | $13.10B | $12.62B |
| Total Assets | $86.31B | $86.82B | $85.99B | $86.08B | $82.70B | $80.15B | $82.55B | $80.22B | $80.35B | $80.81B |
| Current Liabilities | $15.39B | $15.20B | $16.19B | $14.71B | $14.48B | $14.54B | $14.05B | $13.50B | $14.39B | $15.72B |
| Long-term Debt | $19.86B | $20.68B | $18.59B | $19.70B | $17.61B | $15.34B | $17.48B | $16.93B | $15.23B | $13.40B |
| Total Liabilities | $46.22B | $47.08B | $45.91B | $46.09B | $43.24B | $40.66B | $41.94B | $40.66B | $40.12B | $39.72B |
| Stockholders' Equity | $38.57B | $38.24B | $38.62B | $38.52B | $38.03B | $38.09B | $39.17B | $38.18B | $38.83B | $39.72B |
| Retained Earnings | $17.64B | $16.61B | $15.80B | $14.60B | $13.54B | $12.63B | $11.59B | $10.72B | $9.71B | $8.85B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.24B | - | - | - | $2.16B | - | - | - | $1.95B | - |
| Investing Cash Flow | ($1.38B) | - | - | - | ($1.37B) | - | - | - | ($1.04B) | - |
| Financing Cash Flow | ($1.97B) | - | - | - | ($388.00M) | - | - | - | ($668.00M) | - |
| CapEx | $1.34B | - | - | - | $1.27B | - | - | - | $1.05B | - |
| Free Cash Flow | $898.00M | - | - | - | $891.00M | - | - | - | $906.00M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 27.8% | - | 27.5% | 27.7% | 26.9% | - | 25.0% | 26.4% | 25.9% | - |
| EBITDA margin | 38.6% | - | 38.6% | 38.8% | 38.1% | - | 36.5% | 38.0% | 37.6% | - |
| Net margin | 21.1% | - | 22.4% | 20.8% | 20.6% | - | 18.5% | 20.1% | 20.1% | - |
| Free cash flow margin | 10.2% | - | - | - | 11.0% | - | - | - | 11.2% | - |
| FCF / Net income | 0.48 | - | - | - | 0.53 | - | - | - | 0.56 | - |
| R&D / Revenue | 0.4% | - | 0.4% | 0.4% | 0.5% | - | 0.4% | 0.4% | 0.5% | - |
| SG&A / Revenue | 10.2% | - | 10.4% | 10.2% | 9.7% | - | 9.8% | 10.2% | 10.6% | - |
| Effective tax rate | 23.5% | - | 18.0% | 24.5% | 23.4% | - | 24.3% | 23.4% | 22.2% | - |
| Return on assets | 2.2% | - | 2.2% | 2.1% | 2.0% | - | 1.9% | 2.1% | 2.0% | - |
| Return on equity | 4.8% | - | 5.0% | 4.6% | 4.4% | - | 4.0% | 4.4% | 4.2% | - |
| Return on invested capital | 3.2% | - | 3.4% | 3.1% | 3.0% | - | 2.8% | 3.0% | 3.0% | - |
| Liquidity | ||||||||||
| Current ratio | 0.83 | 0.88 | 0.82 | 0.93 | 0.94 | 0.89 | 0.96 | 0.95 | 0.91 | 0.80 |
| Quick ratio | 0.69 | 0.74 | 0.69 | 0.78 | 0.80 | 0.76 | 0.81 | 0.80 | 0.76 | 0.67 |
| Cash ratio | 0.26 | 0.33 | 0.28 | 0.33 | 0.37 | 0.33 | 0.37 | 0.34 | 0.34 | 0.30 |
| Leverage | ||||||||||
| Debt / Equity | 0.51 | 0.54 | 0.48 | 0.51 | 0.46 | 0.40 | 0.45 | 0.44 | 0.39 | 0.34 |
| Debt / Assets | 0.23 | 0.24 | 0.22 | 0.23 | 0.21 | 0.19 | 0.21 | 0.21 | 0.19 | 0.17 |
| Debt / EBITDA | 5.86 | - | 5.59 | 5.98 | 5.69 | - | 5.74 | 5.39 | 5.00 | - |
| Interest coverage | 39.3x | - | 37.0x | 35.1x | 33.6x | - | 52.1x | 42.0x | - | - |
| Equity multiplier | 2.24 | 2.27 | 2.23 | 2.23 | 2.17 | 2.10 | 2.11 | 2.10 | 2.07 | 2.03 |
| Liabilities / Assets | 0.54 | 0.54 | 0.53 | 0.54 | 0.52 | 0.51 | 0.51 | 0.51 | 0.50 | 0.49 |
| Efficiency | ||||||||||
| Asset turnover | 0.10 | - | 0.10 | 0.10 | 0.10 | - | 0.10 | 0.10 | 0.10 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 221d | - | 226d | 225d | 223d | - | 213d | 221d | 226d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 124.6x | - | 116.1x | 125.8x | 132.7x | - | 148.1x | 127.6x | 138.6x | - |
| P / B | 6.0x | - | 5.8x | 5.8x | 5.8x | - | 5.9x | 5.6x | 5.8x | - |
| P / S | 26.3x | - | 26.0x | 26.2x | 27.3x | - | 27.4x | 25.6x | 27.8x | - |
| EV / EBITDA | 72.9x | - | 71.5x | 71.9x | 75.7x | - | 79.3x | 71.4x | 77.5x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 8.2% | - | 3.1% | 2.8% | 0.1% | - | 2.5% | 0.8% | -1.1% | - |
| Revenue CAGR (3y) | 2.3% | - | -0.7% | 0.1% | -0.4% | - | 2.9% | 2.9% | 3.8% | - |
| Revenue CAGR (5y) | 3.9% | - | 4.7% | 5.9% | 3.8% | - | 3.6% | 2.8% | 3.1% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 11.7% | - | 13.5% | 7.8% | 4.2% | - | 1.7% | 8.6% | 8.4% | - |
| Net income growth (YoY) | 11.0% | - | 24.5% | 6.2% | 2.8% | - | -1.0% | 5.6% | 7.3% | - |
| EPS growth (YoY) | 13.4% | - | 27.0% | 8.4% | 4.8% | - | 0.9% | 7.8% | 9.5% | - |
| EPS CAGR (3y) | 9.2% | - | 17.2% | 71.5% | 15.1% | - | 19.6% | 29.1% | 21.7% | - |
| EPS CAGR (5y) | 16.4% | - | 25.4% | 33.8% | 26.8% | - | 19.0% | 15.8% | 28.9% | - |
| FCF growth (YoY) | 0.8% | - | - | - | -1.7% | - | - | - | -16.0% | - |
| FCF CAGR (5y) | 8.9% | - | - | - | 10.4% | - | - | - | - | - |
| Book value growth (YoY) | 1.4% | 0.4% | -1.4% | 0.9% | -2.1% | -4.1% | 0.7% | -4.3% | -2.9% | -0.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$33.99B totalAmericas Segment$15.21B · 44.7%
EMEASegment$8.55B · 25.2%
APACSegment$6.66B · 19.6%
Engineering Segment$2.25B · 6.6%
Corporate And Other$1.32B · 3.9%
Geographic
$33.99B totalUS$12.18B · 35.8%
Other International$11.26B · 33.1%
CN$2.60B · 7.7%
DE$2.43B · 7.2%
GB$1.51B · 4.4%
MX$1.39B · 4.1%
BR$1.32B · 3.9%
AU$1.29B · 3.8%
Peer comparison
Same SIC group: Industrial Inorganic Chemicals
Comparing LINDE PLC against the 5 most active filers in the same SIC group.
Dividends
$4.60/share trailing 12 months · -20.4% YoY
| Ex-date | Per share |
|---|---|
| Mar 11, 2026 | $1.6000 |
| Dec 3, 2025 | $1.5000 |
| Sep 4, 2025 | $1.5000 |
| Jun 4, 2025 | $1.5000 |
| Mar 13, 2025 | $1.5000 |
| Dec 3, 2024 | $1.3900 |
| Sep 4, 2024 | $1.3900 |
| Jun 4, 2024 | $1.3900 |
| Mar 13, 2024 | $1.3900 |
| Dec 1, 2023 | $1.2750 |
| Sep 1, 2023 | $1.2750 |
| Jun 1, 2023 | $1.2750 |
| Mar 13, 2023 | $1.2750 |
| Dec 1, 2022 | $1.1700 |
| Sep 1, 2022 | $1.1700 |
| Jun 2, 2022 | $1.1700 |
| Mar 10, 2022 | $1.1700 |
| Dec 2, 2021 | $1.0600 |
| Sep 2, 2021 | $1.0600 |
| Jun 2, 2021 | $1.0600 |
| Mar 4, 2021 | $1.0600 |
| Dec 2, 2020 | $0.9630 |
| Sep 2, 2020 | $0.9630 |
| Jun 2, 2020 | $0.9630 |